Feasibility and Efficacy of Intravenous Ferric Derisomaltose to Correct Pre-operative Iron-deficiency Anemia in Patients Undergoing Gynecologic Oncology Surgery: a Pilot Randomized Double Blinded Parallel Group Placebo-controlled Study
Latest Information Update: 29 Apr 2025
At a glance
- Drugs Ferric derisomaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- Acronyms FORGE-II
Most Recent Events
- 25 Apr 2025 Planned End Date changed from 30 Dec 2025 to 30 Dec 2026.
- 25 Apr 2025 Planned primary completion date changed from 30 Sep 2025 to 30 Dec 2026.
- 25 Apr 2025 Status changed from not yet recruiting to recruiting.